INTRODUCTION: Meningiomas are usually slow-growing tumours, constituting about one third of all primary intracranial tumours. They occur more frequently in women. Clinical manifestation of meningiomas depends on their location, tumour size and growth rate. In most cases, surgical treatment is the procedure of choice. The success of this treatment is, however, associated with the radicality of the resection. Radiotherapy represents an additional or alternative treatment modality. Gamma knife surgery is another notable treatment method, especially in small and/or slow-growing tumours in eloquent areas or in elderly patients. MATERIAL AND METHODS: Authors describe their experience with the diagnosis, treatment and outcome of the patients with meningioma (n = 857). Furthermore, they also assess the postoperative morbidity/mortality and recurrence rate. RESULTS AND CONCLUSIONS: In view of the benign histology of meningiomas, the success of the treatment largely depends (besides the tumour grading) on the radicality of the resection. The emphasis is also put on appropriate follow-up of the patients. In certain patients, the watch and wait strategy should be also considered as a suitable treatment method.

Central European Institute of Technology Brno Czech Republic

Department of Anaesthesia Resuscitation and Intensive Medicine University Hospital Brno Brno Czech Republic

Department of Neurosurgery University Hospital Brno Brno Czech Republic

Faculty of Medicine Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–1251. doi: 10.1093/neuonc/noab106. PubMed DOI PMC

Rockhill J, Mrugala M, Chamberlain MC. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus. 2007;23:111–117. doi: 10.3171/FOC-07/10/E1. PubMed DOI

Larjavaara S, Haapasalo H, Sankila R, Helén P, Auvinen A. Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer. 2008;99:182–184. doi: 10.1038/sj.bjc.6604438. PubMed DOI PMC

Buerki RA, Horbinski CM, Kruser T, et al. An overview of meningiomas. Future Oncol. 2018;14(21):2161–2177. doi: 10.2217/fon-2018-0006. PubMed DOI PMC

Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018;18(3):241–249. doi: 10.1080/14737175.2018.1429920. PubMed DOI

Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20:22–39. doi: 10.1136/jnnp.20.1.22. PubMed DOI PMC

Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, Parsa AT. The relevance of Simpson grade I and II resection in modern neurosurgical treatment of World Health Organization grade I meningiomas. J Neurosurg. 2010;113(5):1029–1035. doi: 10.3171/2010.3.JNS091971. PubMed DOI

Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307–314. doi: 10.1007/s11060-010-0386-3. PubMed DOI PMC

Santacroce A, Walier M, Régis J, Liščák R, Motti E, Lindquist C. Long-term tumour control of benign intracranial meningiomas after radiosurgery in a series of 4,565 patients. Neurosurg. 2012;70(1):32–39. doi: 10.1227/NEU.0b013e31822d408a. PubMed DOI

Solheim O, Torsteinsen M, Johannesen TB, Jakola AS. Effects of cerebral magnetic resonance imaging in outpatients on observed incidence of intracranial tumours and patient survival: a national observational study. J Neurosurg. 2014;120:827–832. doi: 10.3171/2013.12.JNS131312. PubMed DOI

Behling F, Fodi C, Hoffmann E. The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy. Neurosurg Rev. 2021;44(4):2329–2336. doi: 10.1007/s10143-020-01428-7. PubMed DOI PMC

Wang L, Shengpan L, Yan Z, Hongqi R. The biological and diagnostic roles of microRNAs in meningiomas. Rev Neurosci. 2020;31(7):771–778. doi: 10.1515/revneuro-2020-0023. PubMed DOI

Slavik H, Balik V, Vrbkova J. Identification of meningioma patients at high risk of tumour recurrence using microRNA profiling. Neurosug. 2020;87(5):1055–1063. doi: 10.1093/neuros/nyaa009. PubMed DOI PMC

Bendszus M, Rao G, Burger R, Schaller C, Scheinemann K, Warmuth-Metz M, Hofmann E, Schramm J, Roosen K, Solymosi L. Is there a benefit of preoperative meningioma embolization? Neurosurgery. 2000;47(6):1306–1322. doi: 10.1097/00006123-200012000-00008. PubMed DOI

Chang HC, Thompson NI. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg. 2004;60:52–60. doi: 10.3171/jns.1984.60.1.0052. PubMed DOI

Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307–314 PubMed PMC

Koehorst SG, Jacobs HM, Thijssen JH, Blankenstein MA. Detection of an oestrogen receptor-like protein in human meningiomas by band shift assay using a synthetic oestrogen responsive element (ERE) Br J Cancer. 1993;68(2):290–294. doi: 10.1038/bjc.1993.330. PubMed DOI PMC

Perrot-Applanat M, Groyer-Picard MT, Kujas M. Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir. 1992;115(1–2):20–30. doi: 10.1007/BF01400586. PubMed DOI

Alexiou GA, Markoula S, Gogou P, Kyritsis AP. Genetic and molecular alterations in meningiomas. Clin Neurol Neurosurg. 2011;113(4):261–267. doi: 10.1016/j.clineuro.2010.12.007. PubMed DOI

Dumanski JP, Carlbom E, Collins VP. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci. 1987;84:9275–9279. doi: 10.1073/pnas.84.24.9275. PubMed DOI PMC

Seizinger BR, de la Monte S, Atkins L. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci. 1987;84:5419–5423. doi: 10.1073/pnas.84.15.5419. PubMed DOI PMC

Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. Neurosurg Focus. 1997;2(4):44–57. doi: 10.3171/foc.1997.2.4.6. PubMed DOI

Rydzewski NR, Lesniak MS, Chandler JP, Kalapurakal JA, Pollom E, Tate MC, Bloch O, Kruser T, Dalal P, Sachdev S. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Cancer. 2018;124:734–742. doi: 10.1002/cncr.31088. PubMed DOI

Gerlach R, Raabe A, Scharrer I, Meixensberger J, Seifert V. Post-operative hematoma after surgery for intracranial meningiomas: causes, avoidable risk factors and clinical outcome. Neurol Res. 2004;26:61–66. doi: 10.1179/016164104773026543. PubMed DOI

Schul DB, Wolf S, Krammer MJ, Landscheidt JF, Tomasino A, Lumenta CB. Meningioma surgery in the elderly: outcome and validation of two proposed grading scores systems. Neurosurgery. 2011;23(4):342–351. PubMed

Pannullo SC, Fraser JF, Moliterno J, Cobb W, Stieg PE. Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease. J Neurooncol. 2011;103(1):1–17. doi: 10.1007/s11060-010-0360-0. PubMed DOI

Ahmeti H, Borzikowsky C, Hollander D, et al. Risks and neurological benefits of meningioma surgery. J Neurooncol. 2021;154(3):335–344. doi: 10.1007/s11060-021-03832-5. PubMed DOI PMC

Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery. 2003;53:62–81. doi: 10.1227/01.NEU.0000068730.76856.58. PubMed DOI

Nishizaki T, Ozaki S, Kwak T, Ito H. Clinical features and surgical outcome in patients with asymptomatic meningiomas. Br J Neurosurg. 1999;13:52–55. doi: 10.1080/02688699944186. PubMed DOI

Amano T, Nakamizo A, Michiwaki Y, et al. Surgical outcome in elderly patients with intracranial meningioma. J Clin Neurosci. 2018;56:63–66. doi: 10.1016/j.jocn.2018.07.009. PubMed DOI

Kim YJ, Kang J, Kim MJ. Development and validation of the CLASS score to predict mortality in stage IV solid cancer patients with septic shock in the emergency department: a multi-center, prospective cohort study. Korean Shock Society (KoSS) investigators. BMC Med. 2020;18(1):390. doi: 10.1186/s12916-020-01875-5. PubMed DOI PMC

Monden D, Raimann FJ, Neef V. Meningioma surgery in patients ≥ 70 years of age: clinical outcome and validation of the SKALE score. J Clin Med. 2021;10:1820–1824. doi: 10.3390/jcm10091820. PubMed DOI PMC

Horvath B, Kloesel B, Todd MM. The evolution, current value, and future of the American Society of Anesthesiologists physical status classification system. Anesthesiology. 2021;135(5):904–919. doi: 10.1097/ALN.0000000000003947. PubMed DOI

Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA. Stereotactic radiosurgery provides equivalent tumour control to Simpson grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys. 2003;55(4):1000–1005. doi: 10.1016/S0360-3016(02)04356-0. PubMed DOI

Goldbrunner R, Stavrinou P, Jenkinson MD. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021;23(11):1821–1834. doi: 10.1093/neuonc/noab150. PubMed DOI PMC

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF et al. (2019) International consortium on meningiomas. advances in multidisciplinary therapy for meningiomas. Neuro Oncol 21(Suppl 1):18–31 PubMed PMC

Kim L. A narrative review of targeted therapies in meningioma. Chin Clin Oncol. 2020;9(6):76. doi: 10.21037/cco-2020-mbt-01. PubMed DOI

Brokinkel B, Spille DC, Brokinkel C. The Simpson grading: defining the optimal threshold for gross total resection in meningioma surgery. Neurosurg Rev. 2021;44(3):1713–1720. doi: 10.1007/s10143-020-01369-1. PubMed DOI PMC

Younis GA, Sawaya R, DeMonte F. Aggressive meningeal tumours: review of a series. J Neurosurg. 1995;82:17–27. doi: 10.3171/jns.1995.82.1.0017. PubMed DOI

Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys. 2000;46(1):657–661. doi: 10.1016/S0360-3016(99)00349-1. PubMed DOI

Pamir MN, Özduman K. Current decision-making in meningiomas. Handb Clin Neurol. 2020;169:229–252. doi: 10.1016/B978-0-12-804280-9.00015-9. PubMed DOI

Bartek J, Jr, Sjavik K, Forander P, Solheim O, Gulati S, Weber C, Ingebrigtsen T, Jakola AS. Predictors of severe complications in intracranial meningioma surgery: a population-based multicenter study. World Neurosurg. 2015;83:673–678. doi: 10.1016/j.wneu.2015.01.022. PubMed DOI

Jung HW, Yoo H, Paek SH, Choi KS. Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery. 2000;46(3):567–574. doi: 10.1097/00006123-200003000-00008. PubMed DOI